Genetics
How to Advise Patients About Direct-to-Consumer Genetic Testing
BY SUZANNE M. MAHON, RN, DNSC, AOCN, AGN-BC
Surprise, You Are Adopted
BY SUZANNE M. MAHON, RN, DNSC, AOCN, AGN-BC
Benefits and Risks of Direct to Consumer Genetic Testing for Cancer
BY SUZANNE M. MAHON RN, DNSC, AOCN, AGN-BC
FDA Approves Olaparib, a PARP Inhibitor, for BRCA+ Breast Cancer
BY JASON M. BRODERICK
Megan Hoffman on the Importance of Nurses Understanding Genomics
BY MEGAN HOFFMAN, MSN, RN, CMSRN, AOCNS
Megan Hoffman on Adding the Nurse's Voice to Pharmacogenomics
BY MEGAN HOFFMAN, MSN, RN, CMSRN, AOCNS
Krista Qualmann on Genetic Counseling and Testing for Patients with Cancer
BY KRISTA QUALMANN, MS, CGC
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.